SuperworthAbvc Biopharma market cap ABVC
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $27.7M
- Highest close in our data
- $528.8M
- Feb 2016
Abvc Biopharma is worth $27.7M at the close on Oct 23, 2026, at $1.04 a share.
That is down 60% over the last year and down 55% over five years.
Its highest close in our data was $528.8M in Feb 2016.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $27.7M | $22.1M | $53.2M | −53% |
| 2025 | $59.1M | $5.7M | $77.7M | +683% |
| 2024 | $7.5M | $5.9M | $15M | −10% |
| 2023 | $8.4M | $3.2M | $29.7M | −59% |
| 2022 | $20.4M | $20.4M | $97.6M | −79% |
| 2021 | $97M | $49.7M | $134.3M | −9% |
| 2020 | $106.2M | $46.7M | $108.2M | +6% |
| 2019 | $100.3M | $14.9M | $427.9M | −69% |
| 2018 | $320.9M | $320.9M | $427.9M | −25% |
| 2017 | $427.5M | $418.7M | $427.5M | +2% |
| 2016 | $418.7M | $66.4M | $528.8M | −4% |
| 2015 | $434.7M | $21 | $434.7M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Abvc Biopharma's size, closest first, today.
| Company | Market cap |
|---|---|
| ABVCAbvc Biopharma | $27.7M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Abvc Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.